Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Willow Biosciencesinc (WLLW.CN)

Willow Biosciencesinc (WLLW.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 45,757
  • Shares Outstanding, K 78,892
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 2.99
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.85
Trade WLLW.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -1.75
  • Most Recent Earnings -0.01 on 09/30/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.580 unch
on 12/03/19
0.750 -22.67%
on 11/04/19
-0.170 (-22.67%)
since 11/01/19
3-Month
0.580 unch
on 12/03/19
1.000 -42.00%
on 09/20/19
-0.060 (-9.38%)
since 09/03/19
52-Week
0.530 +9.43%
on 08/19/19
5.250 -88.95%
on 04/15/19
-0.670 (-53.60%)
since 11/30/18

Most Recent Stories

More News
Willow Biosciences Announces Participation In Synbiobeta Panel Discussion

, /PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF), a Canadian biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based...

WLLW.CN : 0.580 (-6.45%)
WLLW.TO : 0.88 (+1.15%)
CANSF : 0.7106 (-1.52%)
Willow Biosciences Announces Annual General and Special Meeting Voting Results

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS./

WLLW.CN : 0.580 (-6.45%)
WLLW.TO : 0.88 (+1.15%)
CANSF : 0.7106 (-1.52%)
Willow Biosciences Announces Ground-Breaking Scientific Data for Cannabigerol (CBG) on Human Skin

, /PRNewswire/ -Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has completed a series of studies with its development partner, Signum Biosciences, Inc.,...

WLLW.CN : 0.580 (-6.45%)
WLLW.TO : 0.88 (+1.15%)
CANSF : 0.7106 (-1.52%)
Willow Biosciences Provides Update on Cannabigerol Research Studies and Key Personnel Appointment

, /PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it is undertaking two initiatives to help our customers evaluate and better understand...

WLLW.CN : 0.580 (-6.45%)
WLLW.TO : 0.88 (+1.15%)
CANSF : 0.7106 (-1.52%)
Willow Biosciences Reports Third Quarter 2020 Results and Operational Update

, /PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF) has released its financial and operating results for the three and nine months ended , reporting significant advancement...

WLLW.CN : 0.580 (-6.45%)
WLLW.TO : 0.88 (+1.15%)
CANSF : 0.7106 (-1.52%)
Willow Biosciences Partners with Researchers at the University of Lethbridge and University of Calgary to Study Effects Of Non-Psychoactive Cannabinoids on Pain, Inflammation and Depression

, /PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has agreed to partner with researchers at the and the to study the therapeutic potential...

WLLW.CN : 0.580 (-6.45%)
CANSF : 0.7106 (-1.52%)
Willow Biosciences announces successful production of pure cannabigerol

, /PRNewswire/ - Willow Biosciences Inc. ("" or the "") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has successfully developed a scalable process for producing cannabigerol ("") with...

AMRI : 21.74 (unch)
WLLW.CN : 0.580 (-6.45%)
Willow Biosciences Announces Appointment of Senior Vice President, Sales and Marketing

Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF) is pleased to announce that Christopher Speed has joined the Company as Senior Vice President, Sales and Marketing, effective...

WLLW.CN : 0.580 (-6.45%)
WLLW.TO : 0.88 (+1.15%)
CANSF : 0.7106 (-1.52%)
Willow Biosciences Announces Trading Date on the Toronto Stock Exchange

Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF) announces that it has received final approval from the Toronto Stock Exchange (the "TSX") to list its common shares (the "Common...

WLLW.CN : 0.580 (-6.45%)
Willow Biosciences Comments on Descheduling of Partner's Cannabidiol by U.S. Drug Enforcement Agency

Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF), a Canadian biotechnology company and a leading developer in biosynthetically produced cannabidiol ("CBD"), comments on Purisys,...

WLLW.CN : 0.580 (-6.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.620
1st Resistance Point 0.600
Last Price 0.580
1st Support Level 0.570
2nd Support Level 0.560
3rd Support Level N/A

See More

52-Week High 5.250
Fibonacci 61.8% 3.447
Fibonacci 50% 2.890
Fibonacci 38.2% 2.333
Last Price 0.580
52-Week Low 0.530

See More

Business Summary

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary, Alberta. It produces high purity, plantderived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar